Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02088957 · ClinicalTrials.gov registry record · Phase 2
Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures
A Phase 2 study, sponsored by UCB Biosciences.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT02088957: Clinical Trial Phase 2 study, sponsored by UCB Biosciences.
NCT02088957 is a Phase 2 study that was terminated before completion, run by UCB Biosciences. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02088957, a Phase 2 study, was terminated before completion, sponsored by UCB Biosciences.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the efficacy of Brivaracetam and Phenytoin, both administered intravenously, in adult subjects experiencing nonconvulsive electrographic seizures.
Primary Outcome
Seizure freedom is based on cEEG/vEEG (continuous video electroencephalogram) monitoring.
Interventions
- DRUG Brivaracetam intravenous solution
- DRUG Brivaracetam oral tablets
- DRUG Phenytoin intravenous solution
- DRUG Phenytoin oral tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Why NCT02088957 stopped before completion
NCT02088957 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Brivaracetam intravenous solution is the first listed.
NCT02088957 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02088957 about?
NCT02088957 is a clinical study titled "Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures". The primary objective of this study is to compare the efficacy of Brivaracetam and Phenytoin, both administered intravenously, in adult subjects experiencing nonconvulsive electrographic seizures.
What is the current status of trial NCT02088957?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2014-03. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02088957?
The interventions under investigation include: Brivaracetam intravenous solution (DRUG), Brivaracetam oral tablets (DRUG), Phenytoin intravenous solution (DRUG), Phenytoin oral tablets (DRUG).
Who is sponsoring clinical trial NCT02088957?
This trial is sponsored by UCB Biosciences, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02088957's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia